Mereo BioPharma (MREO) Assets (2017 - 2026)
Mereo BioPharma (MREO) posted quarterly Assets of $40.6 million for Q1 2026, down 40.56% year-over-year from $68.3 million in Q1 2025, and down 11.55% quarter-over-quarter from $45.9 million in Q4 2025.
Mereo BioPharma (MREO) Assets (2017 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Assets for 8 consecutive years, with $40.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets fell 40.56% year-over-year to $40.6 million; the TTM figure through Mar 2026 stood at $40.6 million (down 40.56% YoY), while the FY2025 annual figure was $45.9 million, down 39.89% from the prior year.
- Assets fell to $40.6 million in Q1 2026 per MREO's latest filing, from $45.9 million in the prior quarter.
- Across five years, Assets topped out at $96.1 million in Q2 2024 and bottomed at $40.6 million in Q1 2026.
- Historically, Assets has averaged $65.5 million across 4 years, with a median of $64.6 million in 2023.
- Annual changes were most pronounced in 2025 — Assets grew 22.14% — and 2026, when it slumped 40.56%.
- Mereo BioPharma's Assets stood at $66.5 million in 2023, then advanced by 14.87% to $76.4 million in 2024, then sank by 39.89% to $45.9 million in 2025, then decreased by 11.55% to $40.6 million in 2026.
- Business Quant data shows MREO's Assets at $40.6 million in Q1 2026, $45.9 million in Q4 2025, and $53.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | 19.82 Bn |
| 10 | Mereo BioPharma | 47.73 Mn | 47.73 Mn | - | 34.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 34.71 Mn |
| Mar 31, 2026 | 40.61 Mn |
| Dec 31, 2025 | 45.92 Mn |
| Sep 30, 2025 | 53.60 Mn |
| Jun 30, 2025 | 62.63 Mn |
| Mar 31, 2025 | 68.32 Mn |
| Dec 31, 2024 | 76.39 Mn |
| Sep 30, 2024 | 88.75 Mn |
| Jun 30, 2024 | 96.13 Mn |
| Mar 31, 2024 | 55.94 Mn |
| Dec 31, 2023 | 66.50 Mn |
| Jun 30, 2020 | 136.32 Mn |
| Dec 31, 2019 | 111.15 Mn |
| Jun 30, 2019 | 137.82 Mn |
| Dec 31, 2018 | 86.57 Mn |
| Dec 31, 2017 | 127.90 Mn |